Embryonic stem cells and induced pluripotent stem cells have been found to have inherent molecular differences, making it possible to clearly distinguish between the two cell types.

Living Cell Technologies opens pig breeding facility ahead of xenotransplantation trials to treat type 1 diabetes. [ + ]

Cochlear, Ramsay, ResMed, Biota, Ansell [ + ]

Australian researchers find that interfering RNA delivered via bacterially-derived minicells can target and kill drug resistant tumours. [ + ]

Patrys Limited (ASX:PAB) announces a renounceable pro-rata rights issue to eligible shareholders. [ + ]

The University of Queensland's Australian Institute for Bioengineering and Nanotechnology has created a vaccine matched to the virus found in the first US case of swine flu.

New technology is allowing us to probe the dark matter of the genome, providing further evidence for John Mattick’s no-longer controversial argument that much of the genome, previously thought to be junk DNA, actually codes for a vast network of regulatory RNAs. [ + ]

ResMed, CSL, Biota, Sonic Healthcare, ChemGenex, Sirtex [ + ]

Adult muscle stem cells rather than embryonic stem cells could be the key to treating muscular disorders. [ + ]

Anti-anxiety drug, BNC210, to undergo phase I clinical trial in Adelaide. [ + ]

Hormone adiponectin could be used to better diagnose and treat type 2 diabetes. [ + ]

Calls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here. [ + ]

COH, CSL, RHC, ANN, SRX [ + ]

Researchers have been able to differentiate not only between healthy and cancerous cells but also between metastatic and non-metastatic cancer cells using an array of nanoparticles and polymers.

CSL to evaluate Phosphagenics' TMP technology with the possibility of an expanded collaboration in the future. [ + ]